|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Stock-based compensation expense | |||||
| Accretion of discount on investment securities | |||||
| Amortization of right-of-use operating lease assets | |||||
| Gain on investment in related party | |||||
| Gain on investment in former related party | |||||
| Changes in operating assets and liabilities: | |||||
| Receivable from related party | |||||
| Unbilled receivable from related party | |||||
| Receivable from former related party | |||||
| Unbilled receivable from former related party | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable, accrued expenses and lease liabilities | |||||
| Accounts payable, accrued expenses and operating lease liabilities | |||||
| Deferred revenue | |||||
| Deferred revenue - related party | |||||
| Deferred revenue - former related party | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Purchases of investment securities | |||||
| Proceeds from sales and maturities of investment securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from public offering | |||||
| Payment of issuance costs in connection with public offering | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Proceeds from the pre-closing financing | |||||
| Payment of issuance costs in connection with pre-closing financing | |||||
| Cash acquired in connection with the reverse recapitalization | |||||
| Payment of reverse recapitalization transaction costs | |||||
| Proceeds from issuance of promissory notes payable to related party | |||||
| Repayment of promissory notes payable to related party | |||||
| Proceeds from issuance of Series A convertible preferred stock | |||||
| Payment of issuance costs for Series A convertible preferred stock | |||||
| Proceeds from exercise of pre-funded warrants | |||||
| Proceeds from private placement | |||||
| Payment of issuance costs in connection with the private placement | |||||
| Proceeds from issuance of common stock pursuant to ATM offering, net of issuance costs | |||||
| Net cash provided by financing activities | |||||
| Increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Disclosure | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Conversion of convertible preferred stock into common stock | |||||
| Issuance costs in connection with public offering included in accrued expenses | |||||
| Additions to right-of-use lease assets from new operating lease liabilities | |||||
Loading...